Publications by authors named "Shifeng Lou"

Claim this Profile
A
ATGL suppresses ferroptosis in acute myeloid leukemia cells by modulating the CEBPα/SCD1 axis and induces gilteritinib resistance.
Shiyi Yuan, Ying Zhou, Wenrui Xiao, Ning Liu, Ping Zhang, Shifeng Lou

Cell Death Dis· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and specific differential gene analysis of the TCR immune repertoire in secondary adult HLH lymphocytes.
Yongsheng Chen, Wenrui Xiao, Shiyi Yuan, Cong Wang, Meizhen Shi, Shifeng Lou

Immunol Lett· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring prognostic genes in the immune microenvironment of acute myeloid leukemia via weighted gene co-expression network analysis.
Xiao Hu, Ying Chen, Huan Li, Shifeng Lou, Fengxia Bai

Medicine (Baltimore)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Hetrombopag Versus Thrombopoietin in Promoting Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective, Multicenter, Randomized Controlled Clinical Trial.
Yimei Feng, Linhui Wang, Mingqiang Ren, Dan Wang, Tao Lang, Shifeng Lou

Am J Hematol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and development of an aptamer targeting C-type lectin-like molecule-1 as a biomarker for acute myeloid leukemia: a SELEX approach.
Yiwen Chen, Qinhang Li, Shifeng Lou, Hanqing Zeng, Shu Chen

Front Bioeng Biotechnol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined association of systemic inflammatory response index and prognostic nutritional index with survival among US cancer survivors.
Bingqing Luo, Xiaoyan Tan, Lin Chen, Kang Zhou, Shifeng Lou

BMC Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 6-tsRNA signature for early detection, treatment response monitoring, and prognosis prediction in diffuse large B cell lymphoma.
Jun Rao, Lin Xia, Qiong Li, NaYa Ma, Xinlei Li, Shifeng Lou

Blood Cancer J· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compound heterozygous mutations (p.L68R∗37 and p.T241N) lead to abnormal protein levels and structures in hereditary FVII deficiency.
Bingqing Luo, Xia Wu, Jing Zhu, Shu Chen, Shifeng Lou

Blood Coagul Fibrinolysis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated Liposomal Doxorubicin Combined with Cytarabine and Granulocyte Colony-Stimulating Factor for Treating Newly Diagnosed Older and Unfit Acute Myeloid Leukemia Patients: A Prospective, Single-Center, Single-arm, Phase II Study.
Bingqing Luo, Xiaoyan Tan, Yanfang Zhang, Xiao Hu, Hanqing Zeng, Shifeng Lou

Technol Cancer Res Treat· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mitoxantrone-liposome Sensitizes Acute Myeloid Leukemia to Gilteritinib Treatment.
Shiyi Yuan, Ying Zhou, Yifei Li, Zhe Chen, Wenrui Xiao, Shifeng Lou

J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An investigation of a hemophilia A female with heterozygous intron 22 inversion and skewed X chromosome inactivation.
Xiaoyan Tan, Yi Yang, Xia Wu, Jing Zhu, Teng Wang, Shifeng Lou

Front Genet· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test.
Xiaoyan Tan, Yan Shen, Yu He, Ping Zhang, Shifeng Lou

Hematology· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Afatinib boosts CAR-T cell antitumor therapeutic efficacy via metabolism and fate reprogramming.
Yueyu Dai, Yue Liu, Lingna An, Fangyuan Zhong, Xi Zhang, Shifeng Lou

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antidote-controlled DNA aptamer modulates human factor IXa activity.
Liang Fang, Jin Jin, Zhe Zhang, Shuang Yu, Cheng Tian, Shifeng Lou

Bioorg Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zuberitamab, an innovative anti-CD20 monoclonal antibody, for patients with primary immune thrombocytopenia in China: a randomized, double-blind, placebo-controlled, phase 2 study.
Min Xu, Jinhui Shu, Shenxian Qian, Jingming Guo, Yuping Gong, Shifeng Lou

Lancet Reg Health West Pac· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long non-coding RNA PXN-AS1 promotes glutamine synthetase-mediated chronic myeloid leukemia BCR::ABL1-independent resistance to Imatinib via cell cycle signaling pathway.
Yifei Li, Shiyi Yuan, Ying Zhou, Jingwen Zhou, Xuan Zhang, Shifeng Lou

Cancer Cell Int· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes.
Jie Tian, Yong-Ping Song, Gao-Chong Zhang, Shu-Fang Wang, Xiao-Xiang Chu, Shi-Feng Lou

J Cancer Res Clin Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Stem Cell Transplant for Multiple Myeloma With Heterozygous Thalassemia Variation: Do or Not Do?
Yan-Fang Zhang, Ying Zhang, Zhi-Ming Luo, Yun Luo, Shi-Feng Lou

Exp Clin Transplant· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features and prognostic risk prediction of adult hemophagocytic lymphohistiocytosis: a 9-year retrospective study.
Qunxiang Qiu, Dan Li, Ying Chen, Ying Song, Shifeng Lou

Ann Hematol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived CD19 CAR-T Cells versus Chemotherapy Plus Donor Lymphocyte Infusion for Treatment of Recurrent CD19-positive B-ALL After Allogeneic Hematopoietic Stem Cell Transplantation.
Xu Tan, Xiao-Qi Wang, Cheng Zhang, Xian-Lan Zhao, Han Yao, Shi-Feng Lou

Curr Med Sci· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Augmenter of liver regeneration promotes drug resistance of acute lymphoblastic leukemia through the alteration of mitochondrial functions and the inhibition of the mitochondrial apoptosis pathway.
Jingwen Zhou, Ying Zhou, Shiyi Yuan, Yifei Li, Wenrui Xiao, Shifeng Lou

Eur J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased lymphocyte count before conditioning is associated with BK virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
Xiang-Ting Xie, Yan-Fang Zhang, Ying Zhang, Han-Qing Zeng, Jian-Chuan Deng, Shi-Feng Lou

Int Immunopharmacol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel HLA-A*24:02:159 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual.
Ying Zhang, Zhong-Zheng Zheng, Ke-Ming Du, Lin An, Shi-Feng Lou

HLA· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural-Based Stability Enhancement of Antisense DNA Oligonucleotides.
Jie Zeng, Liang Fang, Tingting Jiang, Mingchun Liu, Wei Li, Shifeng Lou

Macromol Biosci· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety and bioequivalence of the human-derived B-domain-deleted recombinant factor VIII TQG202 for prophylaxis in severe haemophilia A patients.
Yaming Xi, Chenghao Jin, Wei Liu, Hu Zhou, Zhen Wang, Shifeng Lou

Haemophilia· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis